Davinthra Thillainathan

Stock Analyst at Goldman Sachs

(1.16)
# 3,676
Out of 4,520 analysts
35
Total ratings
38.1%
Success rate
-2.2%
Average return

Stocks Rated by Davinthra Thillainathan

Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10$2.15
Current: $2.10
Upside: +2.38%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $31.67
Upside: +0.41%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Maintained: Buy
Price Target: $51.24$52.80
Current: $39.93
Upside: +32.23%
ResMed Inc.
Feb 2, 2026
Maintained: Buy
Price Target: $49.30$53.20
Current: $28.75
Upside: +85.04%
CSL Limited
Oct 29, 2025
Maintained: Buy
Price Target: $304.60$212.10
Current: $123.32
Upside: +71.99%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $7.01
Current: $3.15
Upside: +122.54%
Ramsay Health Care Limited
Sep 11, 2025
Maintained: Hold
Price Target: n/a
Current: $43.12
Upside: -
Healius Limited
Aug 12, 2025
Maintained: Sell
Price Target: $1.20$0.80
Current: $0.38
Upside: +113.33%
Cochlear Limited
Jun 14, 2025
Maintained: Hold
Price Target: n/a
Current: $119.48
Upside: n/a
Sonic Healthcare Limited
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $21.88
Upside: n/a
Initiated Coverage: Hold
Price Target: $3.30
Current: $2.36
Upside: n/a